Positive and Negative Syndrome Scale (PANSS).
Correlation between the Personal and Social Performance scale (PSP) and the Positive and Negative Syndrome Scale (PANSS) in a Greek sample of patients with schizophrenia
7
Item response analysis of the Positive and Negative Syndrome Scale
10
Validation of the Excited Component of the Positive and Negative Syndrome Scale (PANSS-EC) in a naturalistic sample of 278 patients with acute psychosis and agitation in a psychiatric emergency room
11
A rasch model to test the cross-cultural validity in the positive and negative syndrome scale (PANSS) across six geo-cultural groups
18
Use of NON PARAMETRIC Item Response Theory to develop a shortened version of the Positive and Negative Syndrome Scale (PANSS)
24
Effectiveness of second generation antipsychotics: a naturalistic, randomized comparison of olanzapine, quetiapine, risperidone, and ziprasidone
13
Effects of asenapine on agitation and hostility in adults with acute manic or mixed episodes associated with bipolar I disorder
9
Symmetrical treatment of “Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition”, for major depressive disorders
14
Relationship between social and cognitive functions in people with schizophrenia
10
Long-term efficacy and tolerability of quetiapine in patients with schizophrenia who switched from other antipsychotics because of inadequate therapeutic response—a prospective open-label study
8
Subjective well being, drug attitude, and changes in symptomatology in chronic schizophrenia patients starting treatment with new generation antipsychotic medication
9
Effects of Community Mental Health Centers on Oxidative Stress in Patients with Schizophrenia
9
An open-label study of algorithm-based treatment versus treatment-as-usual for patients with schizophrenia
12
Thesis
42
Impact of time of initiation of once-monthly paliperidone palmitate in hospitalized Asian patients with acute exacerbation of schizophrenia: a post hoc analysis from the PREVAIL study
11
<p>Validation of the Chinese Version of the 16-Item Negative Symptom Assessment</p>
8
A Placebo-controlled Trial of Folate with B12 in Patients with Schizophrenia with Residual Symptoms in Ethiopia Using a Sequential Parallel Comparison Design
15
Multi scale analysis of schizophrenia risk genes, brain structure, and clinical symptoms reveals integrative clues for subtyping schizophrenia patients
31
Physical anhedonia in the acute phase of schizophrenia
5
Quality of sleep in patients with schizophrenia is associated with quality of life and coping
5